Source: Reuters Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira. AbbVie has been under pressure to diversify its portfolio as Humira, the world’s…...
![](https://www.qfrsolutions.com/wp-content/uploads/2018/01/CelegeneLogo-777x370.png)
Pharma Celgene, Say Goodbye to Otezla: BMS Agrees to Sell Psoriasis Drug to Clear $74B Merger
Source: FiercePharma With the Federal Trade Commission (FTC) sweating the details of Bristol-Myers Squibb and Celgene’s proposed $74 billion merger, all eyes were on the companies’ combined psoriasis portfolio, which regulators feared would corner the market. The feds found a solution: You can have your merger, but you don’t get…...